{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:47:20Z","timestamp":1761742040902},"reference-count":24,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":173,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2001,7]]},"abstract":"<jats:p><jats:bold>Summary\u2002<\/jats:bold> Hyperkeratotic type tinea pedis is a refractory type of superficial dermatomycosis. Treatment for hyperkeratotic type tinea pedis is mainly with oral antimycotics, such as griseofulvin, and healing is generally considered to be difficult with only topical antimycotics. In this randomized comparative study, the usefulness of a topical application of 1% lanoconazole cream (Astat<jats:sup>\u00ae<\/jats:sup>) monotherapy (group I) was compared with that of combination therapy with 1% lanoconazole cream and 10% urea ointment (Pastaron<jats:sup>\u00ae<\/jats:sup>) (group II) in a series of patients with hyperkeratotic type tinea pedis. The clinical improvement rates (percentage of \u2018marked improvement\u2019 plus \u2018moderate improvement\u2019) was 70.0% in group I and 95.7% in group II. The fungal eradication rate was 5.0% in group I and 43.5% in group II after 4\u2003weeks of treatment, and was 70.0% and 95.7% after 12\u2003weeks of treatment, respectively. The usefulness rate (percentage of \u2018very useful\u2019 plus \u2018useful\u2019) was 70% in group I and 95.7% in group II. Both lanoconazole monotherapy and the combination therapy with 10% urea ointment were highly effective and safe. Both treatments should be recommended for patients with hyperkeratotic type tinea pedis for whom an oral treatment is not appropriate or for whom a sufficient improvement with oral medications cannot be expected.<\/jats:p>","DOI":"10.1046\/j.0933-7407.2001.00607.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T14:48:11Z","timestamp":1047480491000},"page":"181-190","source":"Crossref","is-referenced-by-count":20,"title":["Usefulness of Lanoconazole (Astat<sup>\u00ae<\/sup>) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% Urea Ointment (Pastaron<sup>\u00ae<\/sup>)"],"prefix":"10.1111","volume":"44","author":[{"given":"H.","family":"Tanuma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"1939","article-title":"Treatment of hyperkeratotic type tinea pedis","volume":"37","author":"Tanuma H.","year":"1995","journal-title":"Risho derma. (Tokyo)"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00403.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70073-5"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70294-R"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(09)80122-9"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1997.tb00219.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00317.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2000.00578.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2000.00560.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.33.321"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.33.361"},{"key":"e_1_2_6_13_2","first-page":"103","volume-title":"Recent Progress in Antifungal Chemotherapy.","author":"Takahashi H.","year":"1992"},{"key":"e_1_2_6_14_2","first-page":"461","volume-title":"Recent Progress in Antifungal Chemotherapy","author":"Ohmi T.","year":"1992"},{"key":"e_1_2_6_15_2","first-page":"847","article-title":"Antifungal activity of the new agent lanoconazole in two tinea model","volume":"41","author":"Ohmi T.","year":"1991","journal-title":"Azneim.-Forsch\/Drug Res."},{"key":"e_1_2_6_16_2","first-page":"1192","article-title":"Therapeutic efficacy of Lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations","volume":"47","author":"Niwano Y.","year":"1994","journal-title":"Jpn J. Antibiot"},{"key":"e_1_2_6_17_2","first-page":"150","article-title":"Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations","volume":"48","author":"Niwano Y.","year":"1995","journal-title":"Jpn J. Antibiot"},{"key":"e_1_2_6_18_2","first-page":"345","article-title":"Therapeutic efficacy of lanoconazole in formulation of clinical use of experimental dermatophytosis in guinea pigs","volume":"42","author":"Oka H.","year":"1992","journal-title":"Arzneim.- Forsch\/Drug Res."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.54.954"},{"key":"e_1_2_6_20_2","first-page":"962","article-title":"Optimum application dose establishing double\u2010blind study on the patients with dermatomycosis","volume":"54","author":"TJN\u2010","year":"1992","journal-title":"Nishinihon J. Dermatol."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.54.977"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.54.944"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.55.961"},{"key":"e_1_2_6_24_2","first-page":"2319","article-title":"Parmacokinetic study following topical application of Astat\u00ae cream in tinea pedis patients to evaluate retentivity of lanconazole (LCZ) in the horny layer","volume":"30","author":"Sadakane C.","year":"1996","journal-title":"Clin. Report"},{"key":"e_1_2_6_25_2","first-page":"1056","article-title":"Studies on the Antifungal Activity of the New Imidazole Antimycotic Lanoconazole in vitro activity in the presence of stratum corneum","volume":"4","author":"Niwano Y.","year":"1997","journal-title":"Azrneim.-Forsh\/Drug Res."}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0933-7407.2001.00607.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0933-7407.2001.00607.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:34:51Z","timestamp":1697546091000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0933-7407.2001.00607.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["10.1046\/j.0933-7407.2001.00607.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0933-7407.2001.00607.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}